About 1 in 8 men are diagnosed with prostate cancer during their lifetime. Although many survive, it can develop into ...

Prostate cancer screening, test interpretation and treatment decisions can be complex, particularly as new approaches to care ...

John Douglas, a Long Island physical therapist, was diagnosed with metastatic prostate cancer after pushing for a more ...

Add Yahoo as a preferred source to see more of our stories on Google. A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor growth ...

I f prostate cancer has spread to other areas of your body, your doctor may recommend androgen deprivation therapy (ADT), which halts the production of androgen hormones, especially testosterone.

Know the questions to ask your doctor about metastatic prostate cancer, such as treatment options, lifestyle changes, and ...

Tonight at 7:30, Penn State Health and abc27 will host a special program: “Prostate Cancer: Where Breakthroughs Change Lives”. Viewers will discover breakthroughs in prostate cancer treatment, ...

Advanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called metastatic or stage 4 prostate cancer. While most advanced prostate cancer is ...

The vast majority of people diagnosed with prostate cancer can expect to live long, full lives thanks to improved screening that catches the disease in its early and most treatable stages. But ...

Advanced prostate cancer cases are rising sharply in California, outpacing national trends, according to a new study from UCSF. The alarming trend underscores the need for smarter screening to catch ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...

A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone therapy reduced the risk of prostate tumor growth and slowed symptom ...